Strategic Steps Uphold Fangdd’s Market Presence
Shares of Fangdd Network Group Ltd. (DUO) surged today’s pre-market trading after revealing a strategic layout for 2024, signaling a foray into the real estate stock asset services segment.
Fangdd Network Group shares ascended by an impressive 78.3% to $1.08 during pre-market hours.
Stock Market Rollercoaster: Winners and Losers
Several stocks made significant moves in pre-market trading:
Gainers
- Kidpik Corp. (PIK) soared 311% to $11.10, driven by a recent 1-for 5 reverse stock split.
- Auddia Inc. (AUUD) gained 50.1% to $4.64 following a decline of over 8% on Friday.
- Mesoblast Limited (MESO) rose 28.4% to $2.76 with FDA support for an accelerated approval pathway.
- TC Biopharm (Holdings) Plc (TCBP) climbed 23.6% to $1.31.
- Graphite Bio, Inc. (GRPH) surged 19.4% to $3.75 after a special dividend declaration.
- GDS Holdings Limited (GDS) leaped 17.7% to $7.54 amid reports of potential investments in their data center business.
- SRIVARU Holding Limited (SVMH) advanced 15.7% to $0.2730.
- Kingsoft Cloud Holdings Limited (KC) rose 13.7% to $3.06 ahead of their upcoming financial results announcement.
- Bon Natural Life Limited (BON) surged 13% to $0.4744.
Losers
- Semilux International Ltd. (SELX) plummeted 24.8% to $1.27 following a 69% jump on Friday.
- Lytus Technologies Holdings PTV. Ltd. (LYT) fell 20% to $6.40 after the launch of Lytus Cloud.
- Safe and Green Development Corporation (SGD) dipped 20% to $0.9926 after a substantial jump last Friday.
- Avenue Therapeutics, Inc. (ATXI) tumbled 19% to $0.1555 despite a 10% surge on Friday.
- Tenax Therapeutics, Inc. (TENX) plummeted 18.5% to $3.31.
- Barnes & Noble Education, Inc. (BNED) declined 18.5% to $0.74 following a rescheduled earnings release.
- Psyence Biomedical Ltd. (PBM) dropped 17.1% to $1.75 after a recent surge.
- CERo Therapeutics Holdings, Inc. (CERO) decreased by 15.2% to $3.35 despite a 28% jump previously.
- Immuron Limited (IMRN) tumbled 14.2% to $3.26.
- Ocular Therapeutix, Inc. (OCUL) fell 13.8% to $8.60 ahead of their fourth-quarter financial results.
